Seroprevalence of SARS-CoV-2 IgG Antibodies in Corsica (France), April and June 2020 Scientific literature GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of SARS-CoV-2 in Palestine: a cross-sectional seroepidemiological study. Preprint. Scientific literature GHDx Entry last modified on: Mar 14, 2022
SARS-CoV-2 seroprevalence in the urban population of Qatar: An analysis of antibody testing on a sample of 112,941 individuals. Preprint Scientific literature GHDx Entry last modified on: Mar 14, 2022
A longitudinal seroprevalence study in a large cohort of working adults reveals that neutralising SARS-CoV-2 RBD-specific antibodies persist for at least six months independent of the severity of symptoms. Preprint Scientific literature GHDx Entry last modified on: Jun 18, 2021
COVID-19 and lombardy: TESTing the impact of the first wave of the pandemic Scientific literature GHDx Entry last modified on: Mar 14, 2022
Coronavirus disease 2019 population-based prevalence, risk factors, hospitalization, and fatality rates in southern Brazil Scientific literature GHDx Entry last modified on: Mar 14, 2022
SARS-CoV-2 Seroprevalence Study in Pimpri-Chinchwad, Maharashtra, India Coinciding with Falling Trend - Do the Results Suggest Imminent Herd Immunity? Preprint Scientific literature GHDx Entry last modified on: Mar 14, 2022
Clinical course of coronavirus disease-2019 in pregnancy Scientific literature GHDx Entry last modified on: Mar 14, 2022
SARS-CoV-2 Seroprevalence in Tamil Nadu in October-November 2020. Preprint Scientific literature GHDx Entry last modified on: Mar 14, 2022
Prevalence of COVID-19 in Iran: results of the first survey of the Iranian COVID-19 Serological Surveillance programme Scientific literature GHDx Entry last modified on: May 12, 2022
Circulating anti-SARS-CoV-2 nucleocapsid (N)-protein antibodies and anti-SARS-CoV-2 spike (S)-protein antibodies in an African setting: herd immunity, not there yet! Scientific literature GHDx Entry last modified on: May 12, 2022
Estimation of real-infection and immunity against SARS-CoV-2 in Indian populations. Preprint Scientific literature GHDx Entry last modified on: Apr 8, 2022
SARS-CoV-2 PCR positivity rate and seroprevalence of related antibodies among a sample of patients in Cairo: Pre-wave 2 results of a screening program in a university hospital Scientific literature GHDx Entry last modified on: Mar 14, 2022
Results of a Population-Based Survey to Estimate the Seroprevalence of SARS-CoV-2 Specific IgG Antibodies in Kashmir, India, Seven Months after the Appearance of the First COVID-19 Case. Preprint Scientific literature GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of SARS-CoV-2 Among Frontline Healthcare Personnel During the First Month of Caring for Patients With COVID-19-Nashville, Tennessee Scientific literature GHDx Entry last modified on: Mar 14, 2022
Slow Spread of SARS-CoV-2 in Southern Brazil Over a 6-Month Period: Report on 8 Sequential Statewide Serological Surveys Including 35611 Participants Scientific literature GHDx Entry last modified on: Mar 14, 2022
Prevalence of SARS-CoV-2: An age-stratified, population-based, sero-epidemiological survey in Islamabad, Pakistan. Preprint Scientific literature GHDx Entry last modified on: Mar 14, 2022
Trends in social exposure to SARS-Cov-2 in France. Evidence from the national socio-epidemiological cohort - EPICOV. Preprint Scientific literature GHDx Entry last modified on: May 12, 2022
Serological surveys to inform SARS-CoV-2 epidemic curve: a cross-sectional study from Odisha, India Scientific literature GHDx Entry last modified on: Mar 14, 2022
Clinical Outcomes Among Patients With 1-Year Survival Following Intensive Care Unit Treatment for COVID-19 Scientific literature GHDx Entry last modified on: Apr 14, 2022
SARS-CoV-2 antibody seroprevalence in Lebanon: findings from the first nationwide serosurvey Scientific literature GHDx Entry last modified on: May 12, 2022
United States - California Department of Public Health Daily COVID-19 Updates 2020 California COVID-19 by the Numbers Epi surveillance GHDx Entry last modified on: Apr 28, 2020
Mexico Health Secretary COVID-19 Daily Technical Release Comunicado Técnico Diario COVID-19 MÉXICO Epi surveillance GHDx Entry last modified on: May 12, 2022
Seroprevalence of SARS-CoV-2-Specific IgG Antibodies Among Adults Living in Connecticut: Post-Infection Prevalence (PIP) Study. Preprint Scientific literature GHDx Entry last modified on: Mar 14, 2022
SARS-CoV-2: seroepidemiological pattern in northeastern Bulgaria Scientific literature GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of SARS-CoV-2-Specific Antibodies, Faroe Islands Scientific literature GHDx Entry last modified on: Mar 14, 2022
Characteristics, comorbidities, 30-day outcome and in-hospital mortality of patients hospitalised with COVID-19 in a Swiss area - a retrospective cohort study Scientific literature GHDx Entry last modified on: Mar 14, 2022
Clinical and histological characterization of vesicular COVID-19 rashes: a prospective study in a tertiary care hospital Scientific literature GHDx Entry last modified on: Mar 14, 2022
Incidence and clinical profiles of COVID-19 pneumonia in pregnant women: A single-centre cohort study from Spain Scientific literature GHDx Entry last modified on: Mar 14, 2022
Characteristics and Outcomes of 241 Births to Women With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection at Five New York City Medical Centers Scientific literature GHDx Entry last modified on: Mar 14, 2022
Clinical Findings and Disease Severity in Hospitalized Pregnant Women With Coronavirus Disease 2019 (COVID-19) Scientific literature GHDx Entry last modified on: Mar 14, 2022
Symptoms and Critical Illness Among Obstetric Patients With Coronavirus Disease 2019 (COVID-19) Infection Scientific literature GHDx Entry last modified on: Mar 14, 2022
Prevalence of SARS-CoV-2 infection in asymtomatic pregnant women and their partners in a tertiary care hospital in Portugal Scientific literature GHDx Entry last modified on: Mar 14, 2022
A population-based seroprevalence survey of severe acute respiratory syndrome coronavirus 2 infection in Beijing, China. Preprint. Scientific literature GHDx Entry last modified on: Mar 14, 2022
National Longitudinal Mediators of Psychological Distress During Stringent COVID-19 Lockdown. Preprint. Scientific literature GHDx Entry last modified on: Mar 14, 2022
Netherlands - South Holland CO-FLOW Covid-19 Cohort Study 2020-2023 COVID-19 Follow-up Care Paths and Long-term Outcomes Within the Dutch Health Care System, A Combined Rehabilitation, Pulmonary, and Intensive Care Perspective Survey: Exam - Health facility - Interview - Longitudinal GHDx Entry last modified on: Jan 19, 2022
Seroprevalence of antibodies against SARS-CoV-2 among public community and health-care workers in Alzintan City of Libya. Preprint Scientific literature GHDx Entry last modified on: Mar 14, 2022
Three-quarters attack rate of SARS-CoV-2 in the Brazilian Amazon during a largely unmitigated epidemic Scientific literature GHDx Entry last modified on: May 12, 2022
Infection fatality rate of SARS-CoV2 in a super-spreading event in Germany Scientific literature GHDx Entry last modified on: Jun 17, 2021
Prevalence of SARS-CoV-2 IgG antibodies in an area of northeastern Italy with a high incidence of COVID-19 cases: a population-based study Scientific literature GHDx Entry last modified on: Mar 14, 2022
Coronavirus antibody screening identifies children with mild to moderate courses of PMIS Scientific literature GHDx Entry last modified on: Mar 14, 2022
Clinical Characteristics of Pregnant Women with Covid-19 in Wuhan, China Scientific literature GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Juba, South Sudan: a population-based study Scientific literature GHDx Entry last modified on: Mar 14, 2022
SARS-CoV-2 Seroprevalence and Neutralizing Antibody Response after the First and Second COVID-19 Pandemic Wave in Croatia Scientific literature GHDx Entry last modified on: May 12, 2022
Seroepidemiology of SARS-CoV-2 infections in an urban Nicaraguan population. Preprint Scientific literature GHDx Entry last modified on: Mar 14, 2022
High-Altitude Environment and COVID-19: SARS-CoV-2 Seropositivity in the Highest City in the World Scientific literature GHDx Entry last modified on: Mar 14, 2022
SARS-CoV-2 seroprevalence and associated factors in Manaus, Brazil: baseline results from the DETECTCoV-19 cohort study Scientific literature GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of Anti-SARS-CoV-2 Antibodies among Outpatients in Southwestern Seoul, Korea Scientific literature GHDx Entry last modified on: Mar 14, 2022
Prevalence of SARS-CoV-2 infection and dynamics of antibodies response among previously undiagnosed healthcare workers in a university hospital: A prospective cohort study Scientific literature GHDx Entry last modified on: Mar 14, 2022
A cross-sectional study of immune seroconversion to SARS-CoV-2 in frontline maternity health professionals Scientific literature GHDx Entry last modified on: Mar 14, 2022